{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:36:41Z","timestamp":1793911001603,"version":"4.8.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.rmed.2026.109200","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:28:31Z","timestamp":1791473311000},"page":"109200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Association between complement de-escalation and prognosis in sepsis: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"263","author":[{"given":"Xin","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinzhu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7441-7536","authenticated-orcid":false,"given":"Zhibin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10219","key":"10.1016\/j.rmed.2026.109200_bib1","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.rmed.2026.109200_bib2","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.rmed.2026.109200_bib3","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1001\/jama.2018.9071","article-title":"Association between the New York sepsis care mandate and In-Hospital mortality for pediatric sepsis","volume":"320","author":"Evans","year":"2018","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.rmed.2026.109200_bib4","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/CCM.0000000000002255","article-title":"Surviving Sepsis campaign: international guidelines for management of sepsis and septic shock: 2016","volume":"45","author":"Rhodes","year":"2017","journal-title":"Crit. Care Med."},{"issue":"23","key":"10.1016\/j.rmed.2026.109200_bib5","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMoa1703058","article-title":"Time to treatment and mortality during mandated emergency care for sepsis","volume":"376","author":"Seymour","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.rmed.2026.109200_bib6","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1164\/rccm.201609-1848OC","article-title":"The timing of early antibiotics and hospital mortality in sepsis","volume":"196","author":"Liu","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.rmed.2026.109200_bib7","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/imr.12499","article-title":"The immune system's role in sepsis progression, resolution, and long-term outcome","volume":"274","author":"Delano","year":"2016","journal-title":"Immunol. Rev."},{"issue":"1","key":"10.1016\/j.rmed.2026.109200_bib8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1172\/JCI82224","article-title":"Sepsis-induced immune dysfunction: can immune therapies reduce mortality?","volume":"126","author":"Delano","year":"2016","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.rmed.2026.109200_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.shk.0000105502.75189.5e","article-title":"Role of C5a-C5aR interaction in sepsis","volume":"21","author":"Guo","year":"2004","journal-title":"Shock"},{"issue":"10","key":"10.1016\/j.rmed.2026.109200_bib10","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1128\/iai.61.10.4293-4301.1993","article-title":"Activation of the complement system in baboons challenged with live Escherichia coli: correlation with mortality and evidence for a biphasic activation pattern","volume":"61","author":"de Boer","year":"1993","journal-title":"Infect. Immun."},{"issue":"3","key":"10.1016\/j.rmed.2026.109200_bib11","first-page":"489","article-title":"Endotoxin-induced shock in the rat. A role for C5a","volume":"135","author":"Smedeg\u00e5rd","year":"1989","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.rmed.2026.109200_bib12","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1001\/archsurg.1988.01400290131023","article-title":"Anaphylatoxin formation in sepsis","volume":"123","author":"Bengtson","year":"1988","journal-title":"Arch. Surg."},{"issue":"2","key":"10.1016\/j.rmed.2026.109200_bib13","first-page":"189","article-title":"Serum complement levels and severity of sepsis","volume":"84","author":"Nakae","year":"1994","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"key":"10.1016\/j.rmed.2026.109200_bib14","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.molimm.2018.06.006","article-title":"Role of complement C5a and histones in septic cardiomyopathy","volume":"102","author":"Fattahi","year":"2018","journal-title":"Mol. Immunol."},{"issue":"5","key":"10.1016\/j.rmed.2026.109200_bib15","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s11908-005-0008-y","article-title":"Complement-induced impairment of the innate immune system during sepsis","volume":"7","author":"Albrecht","year":"2005","journal-title":"Curr. Infect. Dis. Rep."},{"issue":"4","key":"10.1016\/j.rmed.2026.109200_bib16","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/08941930600778263","article-title":"The role of complement, C5a and its receptors in sepsis and multiorgan dysfunction syndrome","volume":"19","author":"Flierl","year":"2006","journal-title":"J. Invest. Surg."},{"key":"10.1016\/j.rmed.2026.109200_bib17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.molimm.2016.11.012","article-title":"Complement and sepsis-induced heart dysfunction","volume":"84","author":"Fattahi","year":"2017","journal-title":"Mol. Immunol."},{"issue":"4","key":"10.1016\/j.rmed.2026.109200_bib18","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/SHK.0000000000001031","article-title":"Importance of the complement alternative pathway in serum chemotactic activity during sepsis","volume":"50","author":"Xu","year":"2018","journal-title":"Shock"},{"key":"10.1016\/j.rmed.2026.109200_bib19","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/382463","article-title":"Activated complement factors as disease markers for sepsis","volume":"2015","author":"Charchaflieh","year":"2015","journal-title":"Dis. Markers"},{"issue":"1","key":"10.1016\/j.rmed.2026.109200_bib20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.smim.2013.05.006","article-title":"The role of complement in trauma and fracture healing","volume":"25","author":"Huber-Lang","year":"2013","journal-title":"Semin. Immunol."},{"issue":"12","key":"10.1016\/j.rmed.2026.109200_bib21","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.clinbiochem.2008.05.005","article-title":"High C5a levels are associated with increased mortality in sepsis patients--no enhancing effect by actin-free Gc-globulin","volume":"41","author":"Gressner","year":"2008","journal-title":"Clin. Biochem."},{"issue":"1\u20133","key":"10.1016\/j.rmed.2026.109200_bib22","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.molimm.2006.06.009","article-title":"Complement-related molecular events in sepsis leading to heart failure","volume":"44","author":"Hoesel","year":"2007","journal-title":"Mol. Immunol."},{"issue":"2","key":"10.1016\/j.rmed.2026.109200_bib23","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.4049\/jimmunol.166.2.1193","article-title":"Role of C5a in multiorgan failure during sepsis","volume":"166","author":"Huber-Lang","year":"2001","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.rmed.2026.109200_bib24","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/10512","article-title":"Protective effects of C5a blockade in sepsis","volume":"5","author":"Czermak","year":"1999","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.rmed.2026.109200_bib25","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1553-2712.2010.00713.x","article-title":"Complement activation in emergency department patients with severe sepsis","volume":"17","author":"Younger","year":"2010","journal-title":"Acad. Emerg. Med."},{"issue":"2","key":"10.1016\/j.rmed.2026.109200_bib26","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/SHK.0000000000001504","article-title":"Complement activation in human sepsis is related to sepsis-induced disseminated intravascular coagulation","volume":"54","author":"Abe","year":"2020","journal-title":"Shock"},{"issue":"1","key":"10.1016\/j.rmed.2026.109200_bib27","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13054-023-04344-6","article-title":"Complement activation in severely ill patients with sepsis: no relationship with inflammation and disease severity","volume":"27","author":"de Nooijer","year":"2023","journal-title":"Crit. Care"},{"issue":"1","key":"10.1016\/j.rmed.2026.109200_bib28","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13054-025-05758-0","article-title":"Systematic review and meta-analysis of humoral immunity proteins and mortality in sepsis","volume":"30","author":"Villa","year":"2025","journal-title":"Crit. Care"},{"key":"10.1016\/j.rmed.2026.109200_bib29","first-page":"1644","article-title":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP\/SCCM Consensus Conference Committee","volume":"101","author":"Rc","year":"1992","journal-title":"American College of Chest Physicians\/Society of Critical Care Medicine. Chest"},{"issue":"4","key":"10.1016\/j.rmed.2026.109200_bib30","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s00134-003-1662-x","article-title":"SCCM\/ESICM\/ACCP\/ATS\/SIS international sepsis definitions conference","volume":"29","author":"Levy","year":"2001","journal-title":"Intensive Care Med."},{"issue":"11","key":"10.1016\/j.rmed.2026.109200_bib31","article-title":"Efficacy and safety of vilobelimab (IFX-1), a novel monoclonal Anti-C5a antibody, in patients with early severe sepsis or septic Shock-A randomized, placebo-controlled, double-blind, multicenter, phase IIa trial (SCIENS Study)","volume":"3","author":"Bauer","year":"2021","journal-title":"Crit Care Explor"},{"issue":"7","key":"10.1016\/j.rmed.2026.109200_bib32","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/archsurg.1995.01430070061012","article-title":"Interleukin-1 blockade attenuates mediator release and dysregulation of the hemostatic mechanism during human sepsis","volume":"130","author":"Boermeester","year":"1995","journal-title":"Arch. Surg."},{"issue":"1","key":"10.1016\/j.rmed.2026.109200_bib33","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00003246-200201000-00016","article-title":"A phase II randomized, controlled trial of continuous hemofiltration in sepsis","volume":"30","author":"Cole","year":"2002","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.rmed.2026.109200_bib34","series-title":"Clinical Study and Mechanism of Qingyinghuoxue Tang on Sepsis [Master]","author":"Y","year":"2009"},{"issue":"16","key":"10.1016\/j.rmed.2026.109200_bib35","first-page":"24","article-title":"The effects of baihu ginseng decoction on clinical efficacy, inflammatory mediators, and renal function in patients with sepsis","volume":"20","author":"G","year":"2020","journal-title":"Practical Clin. J. Integrated Tradit. Chin. West. Med."},{"issue":"6","key":"10.1016\/j.rmed.2026.109200_bib36","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1164\/ajrccm.161.6.9903043","article-title":"The effect of glutathione and N-acetylcysteine on lipoperoxidative damage in patients with early septic shock","volume":"161","author":"Ortolani","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"10","key":"10.1016\/j.rmed.2026.109200_bib37","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1097\/00003246-199910000-00003","article-title":"Continuous plasmafiltration in sepsis syndrome. Plasmafiltration in Sepsis Study Group","volume":"27","author":"Reeves","year":"1999","journal-title":"Crit. Care Med."},{"issue":"4","key":"10.1016\/j.rmed.2026.109200_bib38","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/shk.0b013e31804f5921","article-title":"A novel selective extracorporeal intervention in sepsis: immunoadsorption of endotoxin, interleukin 6, and complement-activating product 5a","volume":"28","author":"Schefold","year":"2007","journal-title":"Shock"},{"issue":"4","key":"10.1016\/j.rmed.2026.109200_bib39","first-page":"29","article-title":"Rhubarb Enema+traditional Chinese medicine hot compress combined Western medicine in the treatment of sepsis random parallel control study","volume":"31","author":"H","year":"2017","journal-title":"J. Practical Traditional Chin. Internal Med."},{"issue":"3","key":"10.1016\/j.rmed.2026.109200_bib40","first-page":"113","article-title":"Effect of retention-enema with dachengqi decoction on serum immunology indexes in patients with sepsis","volume":"5","author":"Yan","year":"2013","journal-title":"Res. Integrated Traditional Chin.Western Med."},{"key":"10.1016\/j.rmed.2026.109200_bib41","series-title":"Clinical Study of Qi-Boosting Blood-Quickening Phlegm-detoxizating Therapy on Sepsis","author":"Zhang","year":"2014"},{"issue":"8","key":"10.1016\/j.rmed.2026.109200_bib53","first-page":"797","article-title":"Definitions, diagnostic criteria, key points of TCM syndrome differentiation, and explanations for sepsis (draft)","volume":"16","year":"2007","journal-title":"Chin. J. Emerg. Med."},{"issue":"6","key":"10.1016\/j.rmed.2026.109200_bib54","first-page":"557","article-title":"Chinese guidelines for the management of severe sepsis and septic shock (2014)","volume":"54","year":"2015","journal-title":"Chin. J. Intern. Med."},{"issue":"4","key":"10.1016\/j.rmed.2026.109200_bib55","first-page":"194","article-title":"Expert consensus on diagnosis and treatment of sepsis with integrated traditional Chinese and Western medicine","volume":"25","year":"2013","journal-title":"Chin. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.rmed.2026.109200_bib56","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/CCM.0b013e31827e83af","article-title":"Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012","volume":"41","author":"Dellinger","year":"2013","journal-title":"Crit. Care Med."},{"issue":"12","key":"10.1016\/j.rmed.2026.109200_bib42","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S2213-2600(22)00297-1","article-title":"Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial","volume":"10","author":"Vlaar","year":"2022","journal-title":"Lancet Respir. Med."},{"issue":"6680","key":"10.1016\/j.rmed.2026.109200_bib43","doi-asserted-by":"crossref","DOI":"10.1126\/science.adg7942","article-title":"Persistent complement dysregulation with signs of thromboinflammation in active Long Covid","volume":"383","author":"Cervia-Hasler","year":"2024","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.rmed.2026.109200_bib44","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1124\/pharmrev.120.000072","article-title":"Therapeutic targeting of the complement system: from rare diseases to pandemics","volume":"73","author":"Garred","year":"2021","journal-title":"Pharmacol. Rev."},{"issue":"3","key":"10.1016\/j.rmed.2026.109200_bib45","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1111\/bjh.16916","article-title":"Terminal complement inhibition dampens the inflammation during COVID-19","volume":"190","author":"Kulasekararaj","year":"2020","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.rmed.2026.109200_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108555","article-title":"Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19","volume":"219","author":"Laurence","year":"2020","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.rmed.2026.109200_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108450","article-title":"The first case of COVID-19 treated with the complement C3 inhibitor AMY-101","volume":"215","author":"Mastaglio","year":"2020","journal-title":"Clin. Immunol."},{"issue":"18","key":"10.1016\/j.rmed.2026.109200_bib48","first-page":"1544","article-title":"FDA approves vilobelimab for emergency use in hospitalized adults","volume":"329","author":"Harris","year":"2023","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.rmed.2026.109200_bib49","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1096\/fj.00-0653fje","article-title":"Protective effects of anti-C5a peptide antibodies in experimental sepsis","volume":"15","author":"Huber-Lang","year":"2001","journal-title":"Faseb J"},{"issue":"5","key":"10.1016\/j.rmed.2026.109200_bib50","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nm1753","article-title":"Functional roles for C5a receptors in sepsis","volume":"14","author":"Rittirsch","year":"2008","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.rmed.2026.109200_bib51","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/SHK.0000000000001531","article-title":"Complement as a major inducer of harmful events in infectious sepsis","volume":"54","author":"Fattahi","year":"2020","journal-title":"Shock"},{"issue":"2","key":"10.1016\/j.rmed.2026.109200_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/tropicalmed8020083","article-title":"A practical approach in refining binary outcome for treatment effect of COVID-19 according to geographical diversity","volume":"8","author":"Tzeng","year":"2023","journal-title":"Trop. Med. Infect. Dis."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095461112600569X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095461112600569X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:13:18Z","timestamp":1793909598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095461112600569X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":56,"alternative-id":["S095461112600569X"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2026.109200","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between complement de-escalation and prognosis in sepsis: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2026.109200","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109200"}}